Synthesis and metal complexation properties of Ph-DTPA and Ph-TTHA: Novel radionuclide chelating agents for use in nuclear medicine

Organic and Biomolecular Chemistry

Volumn 3, Issue 3, 2005, Pages 454-461

  Gouin, Sébastien G ^a,b   Gestin, Jean François ^b   Monrandeau, Laurence ^c   Segat Dioury, Fabienne ^d   Meslin, Jean Claude ^a   Deniaud, David ^a  

^a Centre National de la Recherche Scientifique   (France)

^b INSERM   (France)

^c SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^d Bioinformatique et Chimie Moléculaire   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; CHELATION; COMPLEXATION; ETHANOL; RARE EARTH ELEMENTS; SODIUM COMPOUNDS; TUMORS; ULTRAVIOLET SPECTROSCOPY;

DIETHYLENETRIAMINEPENTAACETIC ACID (DTPA); METAL COMPLEXATION; RADIOIMMUNOTHERAPY (RIT); TRIETHYLENETETRAAMINEHEXAACETIC ACID (TTHA);

RADIOISOTOPES;

CHELATING AGENT; DRUG DERIVATIVE; EDETIC ACID; HEAVY METAL; LANTHANIDE; LIGAND; ORGANOMETALLIC COMPOUND; PENTETIC ACID; PH DTPA; PH TTHA; PH-DTPA; PH-TTHA; TRIETHYLENETETRAMINEHEXAACETIC ACID;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; DRUG STABILITY; HUMAN; IN VITRO STUDY; METHODOLOGY; NUCLEAR MEDICINE; RADIOIMMUNOTHERAPY; SERUM; SYNTHESIS;

CHELATING AGENTS; DRUG STABILITY; EDETIC ACID; HUMANS; LIGANDS; METALS, HEAVY; METALS, RARE EARTH; MOLECULAR STRUCTURE; NUCLEAR MEDICINE; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID; RADIOIMMUNOTHERAPY; SERUM;

STAPHYLOCOCCUS PHAGE 3A;

EID: 14244253566     PISSN: 14770520     EISSN: None     Source Type: Journal    
DOI: 10.1039/b413758b     Document Type: Article

References (69)

1. J. F. Chatal, P. Peltier, M. Bardies, A. Chetanneau, I. Resche, M. Mahe and B. Charbonnel, Med. Nucl., Imag. Fonet. Met., 1993, 17, 81-85.
2. T. M. Behr, R. M. Sharkey, M. E. Juweid, R. M. Dunn, R. C. Vagg, Z. Ying, C. H. Zhang, L. C. Swayne, Y. Vardi, J. A. Siegel and D. M. Goldenberg, J. Nucl. Med., 1997, 38, 858-870.
3. P. Remaud, A. Faivre-Chauvet, J. F. Gestin and L. Morandeu, PCT Int. Pat., WO 0240507, 2002.
4. A. G. Cook and P. J. Wood, J. Immunol. Methods, 1994, 171, 227-237.
5. B. S. De Silva and G. S. Wilson, Methods, 2000, 22, 33-43.
6. T. J. Vaughan, J. K. Osbourn and P. R. Tempest, Nat. Biotechnol., 1998, 16, 535-540.
7. P. A. Schubiger, R. Alberto and A. Smith, Bioconj. Chem., 1996, 7, 165-179.
8. A. Pèlegrin, F. Xavier, J. Barbet, J. Bartholeyns, D. Baty, F. Buchegger, J. F. Chatal, F. Dubief, D. Guerreau, A. Gruaz-Guyon, D. Lamotte, L. Leserman, J. P. Mach, B. Robert, J. C. Saccavini, J. L. Teillaud and I. Teulon, Bull. Cancer, 2000, 87, 777-791.
9. J. M. Le Doussal, M. Martin, E. Gautherot, M. Delaage and J. Barbet, Cancer Res., 1990, 50, 3445-3452.
10. K. Iwai, M. Azuma, S. Kondo, S. Seri and Y. Hashifuji, Eur. Pat. Appl., EP 535668, 1993.
11. J. Graeger, T. C. Chao, M. J. Blend, R. W. Atcher, O. A. Gansow, M. W. Brechbiel and T. K. Das Gupta, J. Nud. Med., 1990, 31, 1378-1383.
12. L. Camera, S. Kinuya, K. Garmestani, C. Wu, M. W. Brechbiel, L. H. Pai, T. J. McMurry, O. A. Gansow, I. Pastan, C. H. Paik and J. A. Carrasquillo, J. Nud. Med., 1994, 35, 882-889.
13. M. W. Brechbiel and O. A. Gansow, J. Chem. Soc., Perkin Trans. 1, 1992, 1173-1178.
14. M. W. Brechbiel and K. Deal, PCT Int. Pat., WO 0059896, 2000.
15. L. L. Chappell, K. A. Deal, E. Dadachova and M. W. Brechbiel, Bioconj. Chem., 2000, 11, 510-519.
16. M. A. Williams and H. Rapoport, J. Org. Chem., 1994, 59, 3616-3625.
17. C. W. Grote, D. J. Kim and H. Rapoport, J. Org. Chem., 1995, 60, 6987-6997.
18. I. F. Pickersgill and H. Rapoport, J. Org. Chem., 2000, 65, 4048-4057.
19. P. M. Pathare, D. K. Hamlin, D. S. Wilbur, M. W. Brechbiel and L. A. Bray, J. Labelled Compd Radiopharm., 1998, 595-603.
20. T. J. McMurry, C. G. Pippin, C. Wu, K. A. Deal, M. W. Brechbiel, S. Mirzadeh and O. A. Gansow, J. Med. Chem., 1998, 41, 3546-3549.
21. H. S. Chong, K. Garmestani, L. H. Bryant and M. W. Brechbiel, J. Org. Chem., 2001, 66, 7745-7750.
22. R. C. Mease, S. C. Srivastava and J. F. Gestin, PCT Int. Pat., WO 5089663, 1992.
23. T. A. Bohigian and A. E. Martell, Inorg. Chem., 1965, 4, 1264-1270.
24. A. Loussouarn, A. Ouadi, L. Morandeau, P. Remaud, R. Giles and J. F. Gestin, Tetrahedron Lett., 2003, 44, 3539-3541.
25. R. Fossheim, H. Dugstad and S. G. Dahl, J. Med. Chem., 1991, 41, 3546-3549.
26. R. D. Hancock and A. E. Martell, Chem. Rev., 1989, 89, 1875-1914.
27. A. E. Martell, R. D. Hancock and R. J. Motekaitis, Coord Chem. Rev., 1994, 133, 39-65.
28. S. G. Gouin, J. F. Gestin, K. Joly, A. Loussouarn, A. Reliquet, J. C. Meslin and D. Deniaud, Tetrahedron, 2002, 58, 1131-1136.
29. J. M. Couchet, C. Galaup, P. Tisnès and C. Picard, Tetrahedron Lett., 2003, 44, 4869-4872.
30. M. I. Burguete, B. Escuder, E. García-Espana, S. V. Luis and J. F. Miravet, Tetrahedron, 2002, 58, 2839-2846.
31. B. M. Kim, S. M. So and J. H. Choi, Org. Lett., 2002, 4, 949-952.
32. L. J. Charbonnière, N. Weibel and R. F. Ziessel, J. Org. Chem., 2002, 67, 3933-3936.
33. H. C. Manning, T. Goebel, J. N. Marx and D. J. Bornhop, Org. Lett., 2002, 4, 1075-1078.
34. H. J. Choi, Y. K. Bae, S. C. Kang, Y. S. Park, J. W. Park, W. I. Kim and T. W. Bell, Tetrahedron Lett., 2002, 43, 9385-9389.
35. M. Vlassa, R. Huang, J. E. Jackson and J. L. Dye, Tetrahedron, 2002, 58, 5849-5854.
36. E. F. K. Me Candlish, T. K. Michael, J. A. Neal, E. C. Lingafelter and N. J. Rose, Inorg. Chem., 1978, 17, 1383-1394.
37. J. Sanchiz, P. Esparza, D. Villagra, S. Dominguez, A. Mederos, F. Brito, L. Araujo, A. Sanchez and J. M. Arrieta, Inorg. Chem., 2002, 41, 6048-6055.
38. N. Nakasuka, M. Sawaragi, K. Matsumura and M. Tanaka, Bull. Chem. Soc. Jpn., 1992, 65, 1722-1724.
39. K. Matsumura, N. Nakasuka and M. Tanaka, Inorg. Chem., 1987, 16, 1419-1422.
40. N. Nakasuka, M. Kunimatsu, K. Matsumura and M. Tanaka, Inorg. Chem., 1985, 24, 10-15.
41. E. Chinea, S. Dominguez, A. Mederos, F. Brito, J. M. Arrieta, A. Sanchez and G. Germain, Inorg. Chem., 1995, 34, 1579-1587.
42. O. Reany, T. Gunnlaugsson and D. Parker, J. Chem. Soc., Perkin Trans. 2, 2000, 1819-1831.
43. S. G. Gouin, J. F. Gestin, A. Reliquet, J. C. Meslin and D. Deniaud, Tetrahedron Lett., 2002, 43, 3003-3005.
44. S. G. Gouin, J. F. Gestin, P. Remaud, A. Faivre-Chauvet, J. C. Meslin and D. Deniaud, SYNLETT, 2002, 12, 2080-2082.
45. O. L. Hoyos, M. R. Bermejo, M. Fondo, A. Garcia-Deibe, A. M. Gonzalez, M. Maneiro and R. Pedrido, J. Chem. Soc., Dalton Trans., 2000, 18, 3122-3127.
46. A. E. Jackson and R. A. W. Johnstone, Synthesis, 1976, 685-687.
47. P. Moreau, M. Tinkl, M. Tsukazaki, P. S. Bury, E. J. Griffen, V. Snieckus, R. B. Maharajh, C. S. Kwok, V. V. Somayaji, Z. Peng, T. R. Sykes and A. A. Noujaim, Synthesis, 1997, 1010-1012.
48. M. Achmatowicz and J. Jurczah, Tetrahedron: Asymmetry, 2001, 12, 487-495
49. M. Studer and C. F. Meares, Bioconj. Chem., 1992, 3, 420-423.
50. A. Loussouarn, M. Duflos, E. Benoist, J. F. Chatal, G. Le Baut and J. F. Gestin, J. Chem. Soc., Perkin Trans. 1, 1998, 237-242.
51. E. Brunet, M. T. Alonso, O. Juanes, O. Velasco and J. C. Rodriguez-Ubis, Tetrahedron, 2001, 57, 3105-3116.
52. J. C. Rodriguez-Ubis, M. T. Alonso and E. Brunet, Tetrahedron Lett, 1994, 35, 8461-8464.
53. C. J. Anderson and M. J. Welch, Chem. Rev., 1999, 99, 2219-2234.
54. W. K. A. Louw, I. C. Dorroehl, A. J. Van Rcnsbrg, N. Hugo, A. S. Alberts, O. E. Forsyth, G. Beverly, M. A. Sweetlovc, J. Marais, M. G. Lötter and A. Van Aswegen, Nucl. Med. Biol., 1996, 23, 935-940.
55. P. Smith-Jones, B. Stolz, R. Albert, G. Ruser, U. Briner, H. R. Mäcke and C. Bruns, Nucl. Med. Biol., 1998, 25, 181-188.
56. J. B. Stimmel and F. C. Kull, Nucl. Med. Biol., 1998, 25, 117-125.
57. T. K. Nikula, M. R. Mc Devitt, R. D. Finn, C. Wu, R. W. Kozack, K. Garmestani, M. W. Brechbiel, M. J. Curcio, C. G. Pippin, L. Tiffany-Jones, M. W. Geerlings, C. Apostolidis, R. Molinet, O. A. Gansow and D. A. Scheinberg, J. Nucl. Med., 1999, 40, 166-176.
58. D. E. Milenic, M. Roselli, S. Mirzadesh, C. G. Pippin, O. A. Gansow, D. Colcher, M. W. Brechbiel and J. Schlom, Cancer. Biother. Radiopharm., 2001, 16, 133-146.
59. K. A. Deal, I. A. Davis, S. Mirzadeh, S. J. Kennel and M. W. Brechbiel, J. Med. Chem., 1999, 42, 2988-2992.
60. S. Liu and S. Edwards, Bioconj. Chem., 2001, 12, 7-34.
61. J. M. Siaugue, A. Favre-Ŕeguillon, F. Dioury, G. Plancque, J. Foos, C. Madic, C. Moulin and A. Guy, Eur. J. Inorg. Chem., 2003, 15, 2834-2838.
62. -4 M. The 750 titration points were used to calculate the protonation constant, corresponding to a pH range of 2.5-10.9. The ionic product of water was fixed at 13.78.
63. T. Mioduski, Talanta, 1980, 27, 299-3003.
64. F. Brito, A. Mederos, J. V. Herrera, S. Dominguez and M. Hernandez-Padilla, Polyhedron, 1988, 7, 1187-1195.
65. J. M. Gatez, E. Mercuiny and G. Duyckacrts, Anal. Chim. Acta, 1976, 84, 383-395.
66. A. E. Martell and R. M. Smith, Critical stability constants, volume 4: Inorganic complexes. Plenum Press, New York, 1976.
67. G. Dubois, R. Tripier, S. Brandès, F. Denat and R. Guilard, J. Mater. Chem., 2002, 12, 2255-2261.
68. F. Denat, G. Dubois, R. Tripier, G. Guilard and B. Roux-Fouillet, PCT Eur. Pat. EP, 1070722, 2001.
69. Compound 3a is now commercially available (Intcrchim Intermediates).